IQVIA (IQV): Kewajiban utang agregat

IQVIA Holdings Inc. (IQV) generates revenue through the execution of clinical trials and the sale of analytics. The total debt valuation confirms the resilience of this model, where this metric equals 15.14. High technological potential in AI algorithms complements the stable cash flow from long-term agreements with pharma behemoths, providing the company with strong operational momentum and leadership in digital medicine.

IQV IQVIA Inc.: Gunggung utang perusahaan ing interval 04.07.2022 - 01.11.2026

IQVIA (IQV) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:

Rega saham Quintiles|IQV - Bagan rega target

- data kapitalisasi bursa:

Nilai pasar IQVIA Inc.|IQV - Nilai Total Perusahaan

- indikator kapitalisasi buku:

Nilai Akuntansi saben Saham IQVIA|IQV - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku iqvia.com|IQV - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Kabeh Utang marang Dana Pribadi IQVIA Holdings Inc.|IQV - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal IQVIA Holdings|IQV - Gunggung utang perusahaan|Utang-utang marang nilai buku IQVIA Inc.|IQV - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak IQVIA|Rasio likuiditas perantara iqvia.com

- data bathi bisnis lan rasio investasi:

IQV - Bathi resik perusahaan

Analisis umum perusahaan:IQV - Quintiles

Investors assess an asset's fundamental stability through the balance of equity and debt. The debt_co metric measures total liabilities, identifying the risk of systemic degradation in the event of uncontrolled credit growth. For IQVIA Holdings Inc. (IQV), the value 15.14 reflects the costs of expansion through the acquisition of niche IT developers. This strategy accelerates the digital transformation of clinical trials. The dynamics of these investments are clearly illustrated in the company's liability history.

Pesaing IQVIA Holdings Inc.